Try our Advanced Search for more refined results

Glenmark Generic Blocked In Netherlands Over Early Launch

By Hanna Vioque ( September 10, 2025, 5:43 PM BST) -- Novartis has convinced a Dutch court to stop Glenmark from making or selling a generic medication used to treat low blood platelet levels in the Netherlands after appearing to launch the drug before Novartis' intellectual property rights had expired....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies